knowledge
Previous article:
Psychedelics group wrestles with new pharma identity
Next article: Argenx readies a blockbuster opportunity with drug for autoimmune disease
Next article: Argenx readies a blockbuster opportunity with drug for autoimmune disease
entertainment
focus
-
Top private equity targets in 2023: cardiology, clinical trials, lasers
2025-10-01 01:58 -
Positive childhood experiences can help future health
2025-10-01 00:43 -
Gene editing the human germline: What are the risks?
2025-10-01 00:30 -
Why CTE doesn’t keep Americans from enjoying the Super Bowl
2025-10-01 00:26 -
I was wrong about Geron's blood cancer drug. Now, is it a takeover target?
2025-10-01 00:25 -
Updated Covid vaccine has 54% effectiveness, new study suggests
2025-09-30 23:32